Pleural fluid carcinoembryonic antigen as a biomarker for the discrimination of tumor‐related pleural effusion

To assess the value of tumor biomarkers in the determination of tumor‐related pleural effusion (PE). Cytological examination of the pleural fluid has a limited sensitivity in diagnosing tumor PE.

[1]  Zhenxing Jiang,et al.  Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer , 2015, Asia-Pacific journal of clinical oncology.

[2]  Li-ke Yu,et al.  Diagnostic value of soluble receptor‐binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer , 2015, Asia-Pacific journal of clinical oncology.

[3]  Maoshui Wang,et al.  CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[4]  P. Zhan,et al.  Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions , 2014, Tumor Biology.

[5]  J. M. Porcel,et al.  Pearls and myths in pleural fluid analysis , 2011, Respirology.

[6]  Hai‐Bo Yang,et al.  Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: A meta‐analysis , 2008, Respirology.

[7]  R. Dweik,et al.  Diagnosis and Management of Pleural Effusions: A Practical Approach , 2007, Comprehensive therapy.

[8]  Kan Zhai,et al.  Diagnostic accuracy of tumor markers for malignant pleural effusion: a , 2007 .

[9]  S. Sahn.  Pleural effusions of extravascular origin. , 2006, Clinics in chest medicine.

[10]  J. M. Porcel,et al.  Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. , 2004, Chest.

[11]  A. Tarn,et al.  BTS guidelines for investigation of unilateral pleural effusion in adults. , 2004, Thorax.

[12]  J. M. Porcel,et al.  Etiology and pleural fluid characteristics of large and massive effusions. , 2003, Chest.

[13]  V. Villena,et al.  Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. , 2003, Lung cancer.

[14]  N. Maskell,et al.  BTS guidelines for the investigation of a unilateral pleural effusion in adults , 2003 .

[15]  H. Colt,et al.  Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. , 2000, Chest.

[16]  E. Felip,et al.  Diagnostic utility of CYFRA 21‐1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions , 1999, Cancer.

[17]  R. Light.  Pleural diseases. , 1992, Disease-a-month : DM.

[18]  R. G. Fraser.  DIAGNOSIS OF DISEASES OF THE CHEST , 1978, The Ulster Medical Journal.

[19]  G. Pescetti,et al.  [Pleural effusions]. , 1965, Aggiornamenti clinicoterapeutici.